SYNLAB.com | Home Page | High Value Tests | Contact Results Business Laboratories SYNLAB EUROPEAN LEADER The new SYNLAB Group , formed by the union of LABCO and Synlab , is the leader in human medicine laboratory services in the European market. SYNLAB IN SPAIN AND PORTUGAL The Iberian Peninsula, with a population of more than 56 million inhabitants, constitutes an important market for SYNLAB . EXPANDING COMPANY One of SYNLAB's main competitive advantages is the size of its network, which allows it to cover both nationally and internationally. SYNLAB IN NUMBERS SYNLAB is present in more than 30 countries on 4 continents. CONTACT Contact us. High Value Tests See all High Value Tests Blog See all posts Septina9 Test Colon cancer early detection in blood Read more neoBona The new generation of non-invasive prenatal test Read more ADGen Genetic evaluation of predisposition to Alzheimer's disease Read more BRCA PLUS Hereditary gynecological cancer prevention Read more NutriHealth Advanced nutrigenetic analysis Read more COLONPLUS Hereditary gastrointestinal cancer prevention Read more preconGEN Genetic test for the study of carriers by NGS Read more ISAC test Evaluation of IgE against 112 allergenic proteins Read more Beyond the spring allergy 06/02/2017 Read more Half of the people with Glaucoma are unaware of it. 03/13/2017 Read more 5 tips to take care of your heart this Christmas 12/21/2016 Read more Tips to prevent the flu 11/04/2016 Read more Contact us | Site Map | Privacy Policy | Recommend Site | Add to favorites Back to the start Copyright © 2011-2017 SYNLAB. All rights reserved Follow us on: X

SYNLAB.com | Home Page | High Value Tests | Contact Results Business Laboratories Colon cancer early detection in blood SYNLAB European Leader SYNLAB in Spain and Portugal Expanding Company SYNLAB in Figures Contact Home Page > High Value Tests > Septina9 select your analysis Septina9 Septina9 is a test that allows early detection of colon cancer through a simple blood sample. It has a high sensitivity and specificity and detects the different types of colorectal cancer, regardless of their location. Septina9 has the ϹE-IVD marking as a screening test for colorectal cancer and is the first and only blood screening test approved by the FDA (US Food and Drug Administration; American Food and Drug Administration ) for the early detection of cancer. colorectal. COLON CANCER SEPTINA9 TEST ADVANTAGE INDICATIONS RESULTS REQUIREMENTS Go to the store More information Downloads Share Colorectal cancer is the fourth leading cause of cancer death worldwide, with an annual incidence of more than 740,000 cases in men and 600,000 in women. It is the third most common type of cancer in men and the second in women. Detecting colorectal cancer in the early stages allows the majority of patients to be treated effectively. Contact us | Site Map | Privacy Policy | Recommend Site | Add to favorites Back to the start Copyright © 2011-2017 SYNLAB. All rights reserved Follow us on: